Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors1

Total Page:16

File Type:pdf, Size:1020Kb

Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors1 [CANCER RESEARCH 59, 3199–3205, July 1, 1999] Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors1 John D. Hooper, David L. Nicol, Joanne L. Dickinson,2 Helen J. Eyre, Anthony L. Scarman, John F. Normyle, Melanie A. Stuttgen, Meaghan L. Douglas, Kate A. Lakoski Loveland, Grant R. Sutherland, and Toni M. Antalis3 Cellular Oncology Laboratory, University of Queensland Joint Oncology Program and Queensland Institute of Medical Research, Brisbane, Queensland, 4029 [J. D. H., J. L. D., A. L. S., J. F. N., M. A. S., T. M. A.]; Department of Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, 4102 [D. L. N., M. L. D.]; Centre for Medical Genetics, Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, Adelaide, South Australia, 5006 [H. J. E., G. R. S.]; and Institute for Reproduction and Development, Monash Medical Center, Monash University, Clayton, Victoria 3168 [K. A. L. L.], Australia ABSTRACT testicular tumors have demonstrated loss of heterozygosity on 5q, 11p15.5, 11q13.1, 13q.3, and 16p13.3 (3), suggesting that these re- We have cloned and characterized a cDNA encoding a new human serine gions may contain candidate tumor suppressor genes. proteinase, testisin, that is abundantly expressed only in the testis and is lost Testicular germ cell maturation is dynamic, requiring cell-cell in testicular tumors. The testisin cDNA was identified by homology cloning using degenerate primers directed at conserved sequence motifs within the communication and localized cell-extracellular matrix interactions catalytic regions of serine proteinases. It is 1073 nucleotides long, including (4). Regulation of such processes involves cell surface proteolysis, 942 nucleotides of open reading frame and a 113-nucleotide 3* untranslated which is important not only for matrix remodeling but also for sequence. Northern and dot blot analyses of RNA from a range of normal regulation of growth and differentiation through activation and/or human tissues revealed a 1.4-kb mRNA species that was present only in testis, release of functionally diverse effector molecules, including cyto- which was not detected in eight of eight testicular tumors. Testisin cDNA is kines, growth factors, and cell surface receptors. Not only is charac- predicted to encode a protein of 314 amino acids, which consists of a 19-amino terization of cell surface proteolysis important for understanding germ acid (aa) signal peptide, a 22-aa proregion, and a 273-aa catalytic domain, cell maturation, but cell surface proteinases also constitute potential including a unique 17-aa COOH-terminal hydrophobic extension that is new targets for anticancer therapies. predicted to function as a membrane anchor. The deduced amino acid The serine proteinases are a large multigene family, the members of sequence of testisin shows 44% identity to prostasin and contains features that are typical of serine proteinases with trypsin-like substrate specificity. which participate in proteolytic reactions that are essential to a diverse Antipeptide antibodies directed against the testisin polypeptide detected an range of physiological and pathological processes (5). These enzymes are generally expressed as inactive zymogens; activation results in immunoreactive testisin protein of Mr 35,000–39,000 in cell lysates from COS-7 cells that were transiently transfected with testisin cDNA. Immuno- rapid molecular responses without the requirement for de novo protein staining of normal testicular tissue showed that testisin was expressed in the synthesis. The involvement of serine proteinases during the later cytoplasm and on the plasma membrane of premeiotic germ cells. No staining stages of male germ cell maturation and in fertilization has been was detected in eight of eight germ cell-derived testicular tumors. In addition, documented. The testis-specific serine proteinases human acrosin (6) the testisin gene was localized by fluorescence in situ hybridization to the and mouse TESP-1 and TESP-2 (7) are recognized as playing roles short arm of human chromosome 16 (16p13.3), a region that has been during the final stages of sperm development. Additionally, the pros- associated with allellic imbalance and loss of heterozygosity in sporadic tate epithelial cell serine proteinase, PSA,4 catalyzes the liquefaction testicular tumors. These findings demonstrate a new cell surface serine proteinase, loss of which may have a direct or indirect role in the progression of seminal coagulum (8). Plasminogen activators have been impli- of testicular tumors of germ cell origin. cated in the degradation of tight junctions in the seminiferous tubules of rat testes (9). Furthermore, as yet uncharacterized serine protein- INTRODUCTION ases are also present on sperm cells as they pass through the epidid- ymis and are necessary for the segregation of sperm surface proteins Spermatogenesis, the tightly regulated and dynamic process of male into distinct domains and the attainment of fertilization competence germ cell maturation, occurs in the testis within seminiferous tubules (10, 11). and results in the transformation of a mitotic spermatogonia into a The enzymatic properties of serine proteinases are dependent on a haploid spermatozoan (1). Testicular germ cell tumors arise from catalytic triad of His, Asp, and Ser amino acids (12), which are present immature male germ cells and may differentiate along pathways in motifs that are highly conserved among family members. We have resulting in several different histological patterns (e.g., seminoma, exploited this property in the present study by using a “homology teratoma, yolk sac tumor, and mixed germ cell tumor). Individual cloning” strategy (13–15) to identify a novel serine proteinase. Tes- tumors exhibit one or more of these histological patterns. In contrast tisin is the first serine proteinase to be identified that is expressed by to many other malignancies, underlying genetic mechanisms in tes- germ cells prior to the first meiotic division and likely functions in ticular tumorigenesis have not been substantially defined. Familial proteolytic reactions that are associated with male germ cell matura- forms of testicular carcinoma are rare (2), but studies of sporadic tion. Its loss of expression by testicular tumors of germ cell origin and the localization of the testisin gene to chromosome 16 (16p13.3), a Received 2/18/99; accepted 4/29/99. region of the genome that is subject to loss of heterozygosity and The costs of publication of this article were defrayed in part by the payment of page rearrangement in human testicular cancers, suggest a potential role for charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. testisin as a tumor suppressor in testicular cancer. 1 Supported by grants from the Queensland Cancer Fund, Brisbane, Australia, and AMRAD Operations Pty. Ltd, Melbourne, Australia. J. D. H. was supported by a John Earnshaw Scholarship from the Queensland Cancer Fund and by the Bancroft Scholarship, MATERIALS AND METHODS Queensland Institute of Medical Research. J. L. D. was supported in part by a Dora Lush Post-Graduate Biomedical Scholarship from the National Health and Medical Research Homology Cloning of Testisin cDNA. Homology cloning was performed Council of Australia. by reverse transcription-PCR using degenerate oligonucleotides directed at 2 Present address: The Eye Clinic, University of Tasmania, Hobart, Tasmania, 7000, Australia. 3 To whom requests for reprints should be addressed, at Queensland Institute of 4 The abbreviations used are: PSA, prostate-specific antigen; RACE, rapid amplifica- Medical Research, Post Office Royal Brisbane Hospital, Brisbane, 4029, Queensland, tion of cDNA ends; GST, glutathione S-transferase; FISH, fluorescence in situ hybrid- Australia. Phone: 61 7 3362 0312; Fax: 61 7 3362 0107; E-mail: [email protected]. ization. 3199 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 1999 American Association for Cancer Research. A NOVEL SERINE PROTEINASE LOST IN TESTICULAR CANCER conserved regions of serine proteinases (13–15). Total RNA (5 mg), isolated Hybond-N nylon membranes (Amersham, Aylesbury, United Kingdom) as from the human cervical adenocarcinoma cell line HeLa S3 (ATCC CCL 2.2) described (16). Human multiple-tissue Northern blots and a human multiple- by the method described previously (16), was reverse transcribed at 42°C using tissue dot blot (Clontech, Palo Alto, CA) were obtained commercially. The avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) in multiple-tissue Northern blot contained 2 mg of poly(A)1 RNA per lane. The m m 1 the presence of oligo(dT)12–18 (0.25 g/ l; Pharmacia Biotech, Uppsala, dot blot contained poly(A) RNA from 50 normal adult and fetal tissues Sweden), 50 mM Tris-HCl (pH 8.3), 50 mM KCl, 10 mM MgCl2,10mM DTT, normalized to the mRNA expression levels of eight different housekeeping 32 and 0.5 mM spermidine in a total volume of 20 ml. PCR was performed using genes and ranged from 89 to 514 ng. Blots were hybridized with [ P]dCTP- 1 ml of the reverse transcriptase reaction mixture, 500 ng of each primer, 10 labeled MscI-BamHI testisin(L) fragment (nucleotides 321–861) in Ex- 3 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM dNTPs, and 1–2 pressHyb (Clontech) solution at 65°C and washed to a final stringency of 0.2 units of Taq polymerase (Perkin-Elmer, Norwalk, CT). The primers were: SSC-0.1% SDS at 65°C. The dot blot was washed to a final stringency of 0.13 forward, 59-ACAGAATTCTGGGTIGTIACIGCIGCICAYTG-39; and reverse, SSC-0.5% SDS at 60°C. Blots were reprobed with b-actin cDNA or an 59-ACAGAATTCAXIGGICCICCI(C/G)(T/A)XTCICC-39 (X 5 AorG, oligonucleotide probe for 18S rRNA (16) to confirm RNA loading in each Y 5 CorT;I5 inosine). Cycling conditions were as follows: 2 cycles of 94°C lane. for 2.5 min, 35°C for 2.5 min, and 72°C for 3 min; followed by 33 cycles of Production of Affinity-purified Antipeptide Polyclonal Antibodies.
Recommended publications
  • Purification and Identification of a Binding Protein for Pancreatic
    Biochem. J. (2003) 372, 227–233 (Printed in Great Britain) 227 Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A Satoshi TSUZUKI*1,2,Yoshimasa KOKADO*1, Shigeki SATOMI*, Yoshie YAMASAKI*, Hirofumi HIRAYASU*, Toshihiko IWANAGA† and Tohru FUSHIKI* *Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan, and †Laboratory of Anatomy, Graduate School of Veterinary Medicine, Hokkaido University, Kita 18-Nishi 9, Kita-ku, Sapporo 060-0818, Japan Pancreatic secretory trypsin inhibitor (PSTI) is a potent trypsin of GzmA-expressing intraepithelial lymphocytes in the rat small inhibitor that is mainly found in pancreatic juice. PSTI has been intestine. We concluded that the PSTI-binding protein isolated shown to bind specifically to a protein, distinct from trypsin, on from the dispersed cells is GzmA that is produced in the the surface of dispersed cells obtained from tissues such as small lymphocytes of the tissue. The rGzmA hydrolysed the N-α- intestine. In the present study, we affinity-purified the binding benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT), and the BLT protein from the 2 % (w/v) Triton X-100-soluble fraction of hydrolysis was inhibited by PSTI. Sulphated glycosaminoglycans, dispersed rat small-intestinal cells using recombinant rat PSTI. such as fucoidan or heparin, showed almost no effect on the Partial N-terminal sequencing of the purified protein gave a inhibition of rGzmA by PSTI, whereas they decreased the inhi- sequence that was identical with the sequence of mouse granzyme bition by antithrombin III.
    [Show full text]
  • Molecular Markers of Serine Protease Evolution
    The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Identification of New Substrates and Physiological Relevance
    Université de Montréal The Multifaceted Proprotein Convertases PC7 and Furin: Identification of New Substrates and Physiological Relevance Par Stéphanie Duval Biologie Moléculaire, Faculté de médecine Thèse présentée en vue de l’obtention du grade de Philosophiae doctor (Ph.D) en Biologie moléculaire, option médecine cellulaire et moléculaire Avril 2020 © Stéphanie Duval, 2020 Résumé Les proprotéines convertases (PCs) sont responsables de la maturation de plusieurs protéines précurseurs et sont impliquées dans divers processus biologiques importants. Durant les 30 dernières années, plusieurs études sur les PCs se sont traduites en succès cliniques, toutefois les fonctions spécifiques de PC7 demeurent obscures. Afin de comprendre PC7 et d’identifier de nouveaux substrats, nous avons généré une analyse protéomique des protéines sécrétées dans les cellules HuH7. Cette analyse nous a permis d’identifier deux protéines transmembranaires de fonctions inconnues: CASC4 et GPP130/GOLIM4. Au cours de cette thèse, nous nous sommes aussi intéressé au rôle de PC7 dans les troubles comportementaux, grâce à un substrat connu, BDNF. Dans le chapitre premier, je présenterai une revue de la littérature portant entre autres sur les PCs. Dans le chapitre II, l’étude de CASC4 nous a permis de démontrer que cette protéine est clivée au site KR66↓NS par PC7 et Furin dans des compartiments cellulaires acides. Comme CASC4 a été rapporté dans des études de cancer du sein, nous avons généré des cellules MDA- MB-231 exprimant CASC4 de type sauvage et avons démontré une diminution significative de la migration et de l’invasion cellulaire. Ce phénotype est causé notamment par une augmentation du nombre de complexes d’adhésion focale et peut être contrecarré par la surexpression d’une protéine CASC4 mutante ayant un site de clivage optimale par PC7/Furin ou encore en exprimant une protéine contenant uniquement le domaine clivé N-terminal.
    [Show full text]
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Cell Surface–Anchored Serine Proteases in Cancer Progression and Metastasis
    Cancer and Metastasis Reviews (2019) 38:357–387 https://doi.org/10.1007/s10555-019-09811-7 Cell surface–anchored serine proteases in cancer progression and metastasis Carly E. Martin1,2 & Karin List1,2 Published online: 16 September 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Over the last two decades, a novel subgroup of serine proteases, the cell surface–anchored serine proteases, has emerged as an important component of the human degradome, and several members have garnered significant attention for their roles in cancer progression and metastasis. A large body of literature describes that cell surface–anchored serine proteases are deregulated in cancer and that they contribute to both tumor formation and metastasis through diverse molecular mechanisms. The loss of precise regulation of cell surface–anchored serine protease expression and/or catalytic activity may be contributing to the etiology of several cancer types. There is therefore a strong impetus to understand the events that lead to deregulation at the gene and protein levels, how these precipitate in various stages of tumorigenesis, and whether targeting of selected proteases can lead to novel cancer intervention strategies. This review summarizes current knowledge about cell surface–anchored serine proteases and their role in cancer based on biochemical characterization, cell culture–based studies, expression studies, and in vivo experiments. Efforts to develop inhibitors to target cell surface–anchored serine proteases in cancer therapy will also be summarized. Keywords Type II transmembrane serine proteases . Cancer . Matriptase . Hepsin . TMPRSS2 . TMPRSS3 . TMPRSS4 . Prostasin . Testisin 1 Introduction PRSS31, transmembrane tryptase, and transmembrane prote- ase γ1) is expressed in cells of hematopoietic origin and has The class of serine proteases contains 175 predicted members been studied most extensively in mast cells [2].
    [Show full text]
  • Rat Prostasin (PRSS8) ELISA Kit
    Product Datasheet Rat Prostasin (PRSS8) ELISA Kit Catalog No: #EK8080 Package Size: #EK8080-1 48T #EK8080-2 96T Orders: [email protected] Support: [email protected] Description Product Name Rat Prostasin (PRSS8) ELISA Kit Brief Description ELISA Kit Applications ELISA Species Reactivity Rat (Rattus norvegicus) Other Names CAP1; PROSTASIN; channel-activating protease 1|prostasin Accession No. Q9ES87 Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. The loss rate was determined by accelerated thermal degradation test. Keep the kit at 37C for 4 and 7 days, and compare O.D.values of the kit kept at 37C with that of at recommended temperature. (referring from China Biological Products Standard, which was calculated by the Arrhenius equation. For ELISA kit, 4 days storage at 37C can be considered as 6 months at 2 - 8C, which means 7 days at 37C equaling 12 months at 2 - 8C). Application Details Detect Range:Request Information Sensitivity:Request Information Sample Type:Serum, Plasma, Other biological fluids Sample Volume: 1-200 µL Assay Time:1-4.5h Detection wavelength:450 nm Product Description Detection Method:SandwichTest principle:This assay employs a two-site sandwich ELISA to quantitate PRSS8 in samples. An antibody specific for PRSS8 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyPRSS8 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for PRSS8 is added to the wells.
    [Show full text]
  • Isolation and Characterization of Porcine Ott-Proteinase Inhibitor1),2) Leukocyte Elastase-Inhibitor Complexes in Porcine Blood, I
    Geiger, Leysath and Fritz: Porcine otrproteinase inhibitor 637 J. Clin. Chem. Clin. Biochem. Vol. 23, 1985, pp. 637-643 Isolation and Characterization of Porcine ott-Proteinase Inhibitor1),2) Leukocyte Elastase-Inhibitor Complexes in Porcine Blood, I. By R. Geiger, Gisela Leysath and H. Fritz Abteilung für Klinische Chemie und Klinische Biochemie (Leitung: Prof. Dr. H. Fritz) in der Chirurgischen Klinik Innenstadt der Universität München (Received March 18/June 20, 1985) Summary: arProteinase inhibitor was purified from procine blood by ammonium sulphate and Cibachron Blue-Sepharose fractionation, ion exchange chromatography on DEAE-Cellulose, gel filtration on Sephadex G-25, and zinc chelating chromatography. Thus, an inhibitor preparation with a specific activity of 1.62 lU/mgprotein (enzyme: trypsin; Substrate: BzArgNan) was obtained. In sodium dodecyl sulphate gel electroph- oresis one protein band corresponding to a molecular mass of 67.6 kDa was found. On isoelectric focusing 6 protein bands with isoelectric points of 3.80, 3.90, 4.05, 4.20, 4.25 and 4.45 were separated. The amino acid composition was determined. The association rate constants for the Inhibition of various serine proteinases were measured. Isolierung und Charakterisierung des on-Proteinaseinhibitors des Schweins Leukocyten-oLj-Proteinaseinhibitor-Komplexe in Schweineblut, L Zusammenfassung; arProteinaseinhibitor wurde aus Schweineblut mittels Ammoniumsulfatfallung und Frak- tionierung an Cibachron-Blau-Sepharose, lonenaustauschchromatographie an DEAE-Cellulose, Gelfiltration an Sephadex G-25 und Zink-Chelat-Chromatographie isoliert. Die erhaltene Inhibitor-Präparation hatte eine spezifische Aktivität von 1,62 ITJ/mg Protein (Enzym: Trypsin; Substrat: BzArgNan). In der Natriumdodecyl- sulfat-Elektrophorese wurde eine Proteinbande mit einer dazugehörigen Molekülmasse von 67,6 kDa erhalten.
    [Show full text]
  • Kinetics of Inhibition of Sperm L-Acrosin Activity by Suramin
    FEBS 27291 FEBS Letters 544 (2003) 119^122 Kinetics of inhibition of sperm L-acrosin activity by suramin Josephine M. Hermansa;Ã, Dianne S. Hainesa, Peter S. Jamesb, Roy Jonesb aDepartment of Biochemistry and Molecular Biology, School of Pharmacy and Molecular Sciences, James Cook University, Townsville, Qld 4811, Australia bGamete Signalling Laboratory, The Babraham Institute, Cambridge CB2 4AT, UK Received 7 March 2003; revised 28 April 2003; accepted 29 April 2003 First published online 14 May 2003 Edited by Judit Ova¤di binding molecule [7,8], for facilitating dispersal of the acroso- Abstract Sperm L-acrosin activity is inhibited by suramin, a polysulfonated naphthylurea compound with therapeutic poten- mal matrix [9] and as an activator of protease activated re- tial as a combined antifertility agent and microbicide. A kinetic ceptor 2 (PAR2) on the oolemma following zona penetration analysis of enzyme inhibition suggests that three and four mol- [10]. ecules of suramin bind to one molecule of ram and boar In previous experiments we reported that the drug suramin L-acrosins respectively. Surface charge distribution models of inhibits both the amidase activity of L-acrosin and binding of boar L-acrosin based on its crystal structure indicate several spermatozoa to the zona pellucida (ZP) in vitro [11]. Suramin positively charged exosites that represent potential ‘docking’ is a symmetrical hexasulfonated naphthylurea compound (Fig. regions for suramin. It is hypothesised that the spatial arrange- 1) that was originally synthesised as a trypanocidal agent for ment and distance between these exosites determines the ca- treatment of sleeping sickness in East Africa [12]. Lately, it pacity of L-acrosin to bind suramin.
    [Show full text]
  • Hepsin, a Cell Surface Serine Protease Identified in Hepatoma Cells, Is Overexpressed in Ovarian Cancer
    CANCER RESEARCH 57. 2554-2887. July 5. 9971 Advances in Brief Hepsin, a Cell Surface Serine Protease Identified in Hepatoma Cells, Is Overexpressed in Ovarian Cancer HirotoshiTanimoto,Yan Yan,John Clarke,SoheliaKorourian,KazushiShigemasa,Tim H. Parmley, Groesbeck P. Parham, and Timothy J. O'Brien' Departments of Obstetrics and Gynecology [H. T.. Y. Y.. J. C.. T. H. P.. G. P. P.. T. J. 0.], Pathology (S. K.]. and Biochemistry and Molecular Biology IT. J. 0.1, Unisersily of Arkansas for Medical Sciences, Little Rock. Arkansas 72205-7/99. and Department of Obstetrics and Gynecology. Hiroshima University School of Medicine, Hiroshima, Japan 737 fK. 5.1 Abstract collagenase (3, 10—13).A significant correlation with tumor progres sion and the immunoreactivity for Mr 72,000 type IV collagenase is Extracellular proteases mediate the digestion of neighboring extracel observed in colorectal cancer (3), and the decrease in the Mr 72,000 lular matrix componentsin initial tumor growth, allow sheddingor des type IV collagenase by pharmacological treatment causes loss of the quamation of tumor cells into the surrounding environment, provide the basis for invasion of basement membranes in target metastatic organs, invasive capacity in vitro (10). Here we investigated the expression of and are required for release and activation of many growth and anglo serine proteases in ovarian tumors by selecting conserved domains in genie factors. We identified overexpression of the serine protease hepsin the immediate vicinity of the catalytic triad of histine-aspartic acid gene in ovarian carcinomas and investigated the expression of this gene in and serine. These sentinel amino acids are surrounded by relatively 44 ovarian tumors (12 low malignant potential tumors and 32 carcinomas) well-conserved domains separated by approximately 50—!00 amino and 10 normal ovaries.
    [Show full text]
  • Proteinase Inhibitor Candidates for Therapy of Enzyme-Inhibitor
    iochemistry of PElmoeary Emphysema Edited by: C. Grassi, J. Travis L. Casali, M. Luisetti Foreword by R. Corsico With 41 figures and 26 tables Springer-Verlag London Berlin Heidelberg New York Paris Tokyo Hong Kong Barcelona Budapest Bi & Gi Publishers - Verona Contents 1. Pulmonary Emphysema: What's Going On 1 C. Grassi, M. Luisetti 2. Elastin and the Lung 13 J. M. Davidson 3. An Introduction to the Endopeptidases 27 A. J. Barrett 4. Lung Proteinases and Emphysema 35 J. G. Bieth 5. Proteinases and Proteinase Inhibitors in the Pathogenesis 47 of Pulmonary Emphysema in Humans R. A. Stockley, D. Burnett 6. Multiple Functions of Neutrophil Proteinases and their 71 Inhibitor Complexes J. Travis, J. Potempa, N. Bangalore, A. Kurdowska 7. Kinetics of the Interaction of Human Leucocyte Elastase with 81 Protein Substrates: Implications for Enzyme Inhibition A. Baici 8. Proteinase Inhibitor Candidates for Therapy of 101 Enzyme-Inhibitor Imbalances H. Fritz, J. Collins, M. Jochum 9. Antileucoprotease (Secretory Leucocyte Proteinase Inhibitor), 113 a Major Proteinase Inhibitor in the Human Lung J. A. Kramps, J. Stolk, A. Rudolphus, J. H. Dijkman 10. Synthetic Mechanism-Based and Transition-State Inhibitors for 123 Human Neutrophil Elastase J. C. Powers, C.-M. Kam, Η. Hon, J. Oleksyszyn, E. F. Meyer Jr. 11. Development and Evaluation of Antiproteases as Drugs for Preventing Emphysema G. L. Snider, P. J. Stone, E. C. Lucey 12. Genetic Control of Human Alpha-l-Antitrypsin and Hepatic Gene Therapy S. L. C Woo, R. N. Sifers, K. Ponder 13. Neutrophils, Neutrophil Elastase and the Fragile Lung: The Pathogenesis and Therapeutic Strategies Relating to Lung Derangement in the Common Hereditary Lung Disorders N.
    [Show full text]
  • Protease Activated Receptors and Arthritis
    International Journal of Molecular Sciences Review Protease Activated Receptors and Arthritis Flora Lucena and Jason J. McDougall * Departments of Pharmacology and Anesthesia, Pain Management & Perioperative Medicine, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada; fl[email protected] * Correspondence: [email protected] Abstract: The catabolic and destructive activity of serine proteases in arthritic joints is well known; however, these enzymes can also signal pain and inflammation in joints. For example, thrombin, trypsin, tryptase, and neutrophil elastase cleave the extracellular N-terminus of a family of G protein- coupled receptors and the remaining tethered ligand sequence then binds to the same receptor to initiate a series of molecular signalling processes. These protease activated receptors (PARs) pervade multiple tissues and cells throughout joints where they have the potential to regulate joint homeostasis. Overall, joint PARs contribute to pain, inflammation, and structural integrity by altering vascular reactivity, nociceptor sensitivity, and tissue remodelling. This review highlights the therapeutic potential of targeting PARs to alleviate the pain and destructive nature of elevated proteases in various arthritic conditions. Keywords: arthritis; inflammation; joint damage; proteases; pain 1. Introduction Musculoskeletal diseases comprise the most prevalent chronic pain conditions with Citation: Lucena, F.; McDougall, J.J. arthritides accounting for the majority of these disorders [1]. Although there are over Protease Activated Receptors and 100 different types of arthritis, the most commonly studied are inflammatory rheumatoid Arthritis. Int. J. Mol. Sci. 2021, 22, arthritis (RA) and degenerative osteoarthritis (OA). In RA, an individual’s immune system 9352. https://doi.org/10.3390/ is dysregulated and inflammatory cells begin to destroy the host joint tissues by releasing ijms22179352 chemical mediators into the joint.
    [Show full text]